Published in Tissue Eng on July 06, 2005
Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering. Tissue Eng Part B Rev (2010) 1.76
Scaffolding in tissue engineering: general approaches and tissue-specific considerations. Eur Spine J (2008) 1.68
Heart valve tissue engineering: concepts, approaches, progress, and challenges. Ann Biomed Eng (2006) 1.26
Development of decellularized human umbilical arteries as small-diameter vascular grafts. Tissue Eng Part A (2009) 1.25
Tissue engineering of blood vessel. J Cell Mol Med (2007) 1.20
Extracellular vesicles: potential roles in regenerative medicine. Front Immunol (2014) 1.17
Fabrication of cardiac patch with decellularized porcine myocardial scaffold and bone marrow mononuclear cells. J Biomed Mater Res A (2010) 1.15
Altered structural and mechanical properties in decellularized rabbit carotid arteries. Acta Biomater (2008) 1.14
Novel utilization of serum in tissue decellularization. Tissue Eng Part C Methods (2010) 1.04
Applying elastic fibre biology in vascular tissue engineering. Philos Trans R Soc Lond B Biol Sci (2007) 1.01
Preparation of ex vivo-based biomaterials using convective flow decellularization. Tissue Eng Part C Methods (2009) 1.00
Effect of decellularization protocol on the mechanical behavior of porcine descending aorta. Int J Biomater (2010) 0.85
Structural and biomechanical characterizations of porcine myocardial extracellular matrix. J Mater Sci Mater Med (2012) 0.84
The influence of early-phase remodeling events on the biomechanical properties of engineered vascular tissues. J Vasc Surg (2011) 0.84
Cell-matrix biology in vascular tissue engineering. J Anat (2006) 0.83
Specialized tip/stalk-like and phalanx-like endothelial cells from embryonic stem cells. Stem Cells Dev (2013) 0.82
Cellularized microcarriers as adhesive building blocks for fabrication of tubular tissue constructs. Ann Biomed Eng (2013) 0.79
Mechanocompatible Polymer-Extracellular-Matrix Composites for Vascular Tissue Engineering. Adv Healthc Mater (2016) 0.77
Future Prospects for Scaffolding Methods and Biomaterials in Skin Tissue Engineering: A Review. Int J Mol Sci (2016) 0.75
Mesenchymal stem cells from umbilical cord tissue as potential therapeutics for cardiomyodegenerative diseases - a review. Int J Mol Cell Med (2012) 0.75
Optimum parameters for freeze-drying decellularized arterial scaffolds. Tissue Eng Part C Methods (2013) 0.75
Establishing Early Functional Perfusion and Structure in Tissue Engineered Cardiac Constructs. Crit Rev Biomed Eng (2015) 0.75
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med (2010) 22.04
Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA (2006) 5.95
Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med (2010) 4.77
Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials. Arch Intern Med (2012) 4.55
Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med (2012) 4.47
Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med (2003) 3.85
Ultrastrong and stiff layered polymer nanocomposites. Science (2007) 3.40
Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). J Am Coll Cardiol (2012) 3.29
Vitamin B12 deficiency. Am Fam Physician (2003) 3.01
Public reporting and case selection for percutaneous coronary interventions: an analysis from two large multicenter percutaneous coronary intervention databases. J Am Coll Cardiol (2005) 3.01
A propensity analysis of the impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes after percutaneous coronary intervention. Am J Cardiol (2003) 2.72
Prostatic fibrosis is associated with lower urinary tract symptoms. J Urol (2012) 2.37
Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. Anesthesiology (2002) 2.07
Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med (2006) 1.97
The V-Y advancement flap is equivalent to the Mustardé flap for ectropion prevention in the reconstruction of moderate-size lid-cheek junction defects. Plast Reconstr Surg (2013) 1.94
Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials. JAMA (2005) 1.70
The role of extracellular matrix composition in structure and function of bioengineered skeletal muscle. Biomaterials (2011) 1.68
Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty. Anesthesiology (2003) 1.60
The tensile properties of alginate hydrogels. Biomaterials (2004) 1.57
Rapid formation of functional muscle in vitro using fibrin gels. J Appl Physiol (1985) (2004) 1.56
Use of Acellular Dermal Matrix in Postmastectomy Breast Reconstruction: Are All Acellular Dermal Matrices Created Equal? Plast Reconstr Surg (2015) 1.49
Aspirin use, dose, and clinical outcomes in postmenopausal women with stable cardiovascular disease: the Women's Health Initiative Observational Study. Circ Cardiovasc Qual Outcomes (2009) 1.48
Use of soleus muscle flaps for coverage of distal third tibial defects. J Reconstr Microsurg (2004) 1.46
Management of patients undergoing percutaneous coronary revascularization. Ann Intern Med (2003) 1.44
Evidence-based reports--is there any evidence? Reg Anesth Pain Med (2003) 1.43
The impact of advanced chronic kidney disease on in-hospital mortality following percutaneous coronary intervention for acute myocardial infarction. Catheter Cardiovasc Interv (2007) 1.42
Utility of routine functional testing after percutaneous transluminal coronary angioplasty: results from the ROSETTA registry. J Invasive Cardiol (2004) 1.40
New and simplified method for multiple left ventricle catheterizations in small animals. Interact Cardiovasc Thorac Surg (2008) 1.40
Impact of abciximab on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction treated with primary stenting. Catheter Cardiovasc Interv (2010) 1.39
Lack of Association between Blood Pressure Management by Anesthesia Residents and Competence Committee Evaluations or In-training Exam Performance: A Cohort Analysis. Anesthesiology (2016) 1.38
Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis. Am J Med (2008) 1.37
Contractile skeletal muscle tissue-engineered on an acellular scaffold. Plast Reconstr Surg (2004) 1.34
Transapical aortic valve replacement for severe aortic stenosis: results from the nonrandomized continued access cohort of the PARTNER trial. Ann Thorac Surg (2013) 1.33
Salt fusion: an approach to improve pore interconnectivity within tissue engineering scaffolds. Tissue Eng (2002) 1.33
Bioengineered internal anal sphincter derived from isolated human internal anal sphincter smooth muscle cells. Gastroenterology (2009) 1.31
The combination of meropenem and levofloxacin is synergistic with respect to both Pseudomonas aeruginosa kill rate and resistance suppression. Antimicrob Agents Chemother (2010) 1.27
Structure and functional evaluation of tendon-skeletal muscle constructs engineered in vitro. Tissue Eng (2006) 1.24
Effect of inhibition of the renin-angiotensin system on development of type 2 diabetes mellitus (meta-analysis of randomized trials). Am J Cardiol (2007) 1.23
Self-organization of rat cardiac cells into contractile 3-D cardiac tissue. FASEB J (2004) 1.22
Development of a three-dimensional physiological model of the internal anal sphincter bioengineered in vitro from isolated smooth muscle cells. Am J Physiol Gastrointest Liver Physiol (2005) 1.22
An implantable device for stimulation of denervated muscles in rats. Med Eng Phys (2003) 1.20
Comparison of gene expression of 2-mo denervated, 2-mo stimulated-denervated, and control rat skeletal muscles. Physiol Genomics (2005) 1.19
Incisional herniation induces decreased abdominal wall compliance via oblique muscle atrophy and fibrosis. Ann Surg (2007) 1.19
Microfeature guided skeletal muscle tissue engineering for highly organized 3-dimensional free-standing constructs. Biomaterials (2009) 1.18
Two-surgeon technique of parenchymal transection contributes to reduced transfusion rate in patients undergoing major hepatectomy: analysis of 1,557 consecutive liver resections. Surgery (2009) 1.18
Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation. Ann Thorac Surg (2010) 1.16
Mechanical properties of acellular peripheral nerve. J Surg Res (2003) 1.15
p38γ promotes breast cancer cell motility and metastasis through regulation of RhoC GTPase, cytoskeletal architecture, and a novel leading edge behavior. Cancer Res (2011) 1.15
Engineering of functional tendon. Tissue Eng (2004) 1.14
Three-dimensional engineered bone-ligament-bone constructs for anterior cruciate ligament replacement. Tissue Eng Part A (2011) 1.14
Race, ethnicity, and sociocultural characteristics predict noncompliance with lipid-lowering medications. Prev Med (2004) 1.13
Myocardial engineering in vivo: formation and characterization of contractile, vascularized three-dimensional cardiac tissue. Tissue Eng (2005) 1.13
Competency in electrocardiogram interpretation among internal medicine and emergency medicine residents. Am J Med (2005) 1.13
Early sustained ventricular arrhythmias complicating acute myocardial infarction. Am J Med (2008) 1.12
Are individual differences in fatigue vulnerability related to baseline differences in cortical activation? Behav Neurosci (2005) 1.11
Neurotization improves contractile forces of tissue-engineered skeletal muscle. Tissue Eng (2007) 1.09
Functional evaluation of nerve-skeletal muscle constructs engineered in vitro. In Vitro Cell Dev Biol Anim (2006) 1.09
Number of contractions to maintain mass and force of a denervated rat muscle. Muscle Nerve (2004) 1.09
The impact of revascularization on mortality in patients with nonacute coronary artery disease. Am J Med (2009) 1.09
Aging increases the susceptibility of skeletal muscle derived satellite cells to apoptosis. Exp Gerontol (2006) 1.08
Regional stiffening with aging in tibialis anterior tendons of mice occurs independent of changes in collagen fibril morphology. J Appl Physiol (1985) (2011) 1.07
The keystone island flap: use in large defects of the trunk and extremities in soft-tissue reconstruction. Plast Reconstr Surg (2011) 1.06
Effect of chronic obstructive pulmonary disease on survival of patients with coronary heart disease having percutaneous coronary intervention. Am J Cardiol (2004) 1.05
Development of a scaffoldless three-dimensional engineered nerve using a nerve-fibroblast co-culture. In Vitro Cell Dev Biol Anim (2009) 1.05
Cultured slow vs. fast skeletal muscle cells differ in physiology and responsiveness to stimulation. Am J Physiol Cell Physiol (2006) 1.05
Evaluation of plastic surgery information on the Internet. Ann Plast Surg (2002) 1.05
Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain. J Med Chem (2008) 1.04
A novel device for the study of somatosensory information processing. J Neurosci Methods (2011) 1.03
Effect of diabetes on long-term mortality following contemporary percutaneous coronary intervention: analysis of 4,284 cases. Diabetes Care (2004) 1.03
Progressive fascial wound failure impairs subsequent abdominal wall repairs: a new animal model of incisional hernia formation. Surgery (2005) 1.03
Three-dimensional engineered bone from bone marrow stromal cells and their autogenous extracellular matrix. Tissue Eng Part A (2009) 1.03
Microbial carriage state of peripheral blood dendritic cells (DCs) in chronic periodontitis influences DC differentiation, atherogenic potential. J Immunol (2012) 1.02
Regional variation of tibialis anterior tendon mechanics is lost following denervation. J Appl Physiol (1985) (2006) 1.01
Morphological and functional characteristics of three-dimensional engineered bone-ligament-bone constructs following implantation. J Biomech Eng (2009) 1.00
Resident participation does not affect surgical outcomes, despite introduction of new techniques. J Am Coll Surg (2010) 0.98
A novel bioreactor for stimulating skeletal muscle in vitro. Tissue Eng Part C Methods (2010) 0.98
An evidence-based approach to pressure sores. Plast Reconstr Surg (2011) 0.97
Somatosensory information processing in the aging population. Front Aging Neurosci (2011) 0.96
High-risk patients referred for transcatheter aortic valve implantation: management and outcomes. Ann Thorac Surg (2008) 0.95
In vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae. Antimicrob Agents Chemother (2007) 0.94
Basosquamous carcinoma-an under-recognized, high-risk cutaneous neoplasm: case study and review of the literature. J Plast Reconstr Aesthet Surg (2006) 0.94
Altered central sensitization in subgroups of women with vulvodynia. Clin J Pain (2011) 0.93
Suppression of central chemokine fractalkine receptor signaling alleviates amyloid-induced memory deficiency. Neurobiol Aging (2013) 0.93
Effects of age and nerve-repair grafts on reinnervation and fiber type distribution of rat medial gastrocnemius muscles. Mech Ageing Dev (2003) 0.92
Impact of spores on the comparative efficacies of five antibiotics for treatment of Bacillus anthracis in an in vitro hollow fiber pharmacodynamic model. Antimicrob Agents Chemother (2011) 0.92
Hospital volume outcome and discharge disposition of burn patients. Plast Reconstr Surg (2006) 0.91
Effect of implantation on engineered skeletal muscle constructs. J Tissue Eng Regen Med (2012) 0.90